The menopause-specific quality of life questionnaire: Psychometric evaluation among breast cancer survivors

Menopause

Volumn 18, Issue 3, 2011, Pages 289-295

  Radtke, Jill V ^a   Terhorst, Lauren ^a   Cohen, Susan M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Breast cancer; Factor analysis; Menopause; Psychometrics; Quality of life

Indexed keywords

ACUPUNCTURE; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CLINICAL ASSESSMENT; CONSTRUCT VALIDITY; CONVERGENT VALIDITY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DISCRIMINANT VALIDITY; FEMALE; FOLLOW UP; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MENOPAUSE; MENOPAUSE SPECIFIC QUALITY OF LIFE QUESTIONNAIRE; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRY; QUESTIONNAIRE; RATING SCALE; TEST RETEST RELIABILITY; VALIDITY;

AFFECT; BREAST NEOPLASMS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SURVIVORS; VASOMOTOR SYSTEM;

EID: 79952184912     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181ef975a     Document Type: Article

References (28)

1. Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161-175.
2. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005;50:209-221. (Pubitemid 40269904)
3. Lower EE, Blau R, Gazder P, Tummala R. The risk of premature menopause induced by chemotherapy for early breast cancer. J Womens Health Gend Based Med 1999;8:949-954. (Pubitemid 29501939)
4. Knobf MT. Natural menopause and ovarian toxicity associated with breast cancer therapy. Oncol Nurs Forum 1998;25:1519-1530.
5. Knobf MT. The menopausal symptom experience in young mid-life women with breast cancer. Cancer Nurs 2001;24:201-210. (Pubitemid 32499262)
6. Canney PA, Hatton MQ. The prevalence of menopausal symptoms in patients treated for breast cancer. Clin Oncol (R Coll Radiol) 1994;6: 297-299. (Pubitemid 24310396)
7. NIH State-of-the-Science Conference Statement on management of menopause-related symptoms. NIH Consens State Sci Statements 2005; 22:1-38.
8. Carpenter JS, Andrykowski MA. Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 1999;26:1311-1317.
9. Fenlon DR, Rogers AE. The experience of hot flushes after breast cancer. Cancer Nurs 2007;30:E19-E26. (Pubitemid 47196611)
10. Knobf MT. Carrying on: the experience of premature menopause in women with early stage breast cancer. Nurs Res 2002;51:9-17.
11. Knobf MT. Reproductive and hormonal sequelae of chemotherapy in women. Premature menopause and impaired fertility can result, effects that are especially disturbing to young women. Am J Nurs 2006;106: 60-65.
12. Knobf MT. BComing to grips[ with chemotherapy-induced premature menopause. Health Care Women Int 2008;29:384-399.
13. Tchen N, Juffs HG, Downie FP, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175-4183. (Pubitemid 46606186)
14. Lamping DL, Schroter S, Marquis P, Marrel A, Duprat-Lomon I, Sagnier P-P. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest 2002;122:920-929.
15. Yen M, Lo L-H. Examining test-retest reliability: an intra-class correlation approach. Nurs Res 2002;51:59-62.
16. Hutcheson GD, Sofroniou N, eds. The Multivariate Social Scientist: Introductory Statistics Using Generalized Linear Models. Thousand Oaks CA: Sage Publications 1999.
17. Costello AB, Osborne JW. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. PARE 2005;10:173-178.
18. Alder E. The Blatt-Kupperman menopausal index: a critique. Maturitas 1998;29:19-24. (Pubitemid 28247564)
19. Bandalos DL, Enders CK. The effects of nonnormality and number of response categories on reliability. Appl Meas Educ 1996;9:151-160.
20. Dumenci L, Achenbach TM. Effects of estimation methods on making trait-level inferences from ordered categorical items for assessing psychopathology. Psychol Assess 2008;20:55-62. (Pubitemid 351418232)
21. Nunnally JC Bernstein IH Psychometric Theory, 3rd ed. New York, NY McGraw-Hill. 1994.
22. Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL. Association of waking episodes with menopausal hot flushes. JAMA 1981;245:1741-1744. (Pubitemid 11096223)
23. Perz JM. Development of the menopause symptom list: a factor analytic study of menopause associated symptoms. Women Health 1997;25:53-69. (Pubitemid 27373042)
24. Gelfand MM, Moreau M, Ayotte NJ, Hilditch JR, Wong BA, Lau CY. Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. Menopause 2003;10:29-36. (Pubitemid 36706319)
25. DeVellis RF, ed. Scale Development: Theory and Applications. Thousand Oaks CA: Sage Publications 2003.
26. Hatcher L, ed. A Step-by-Step Approach to Using the SASA System for Factor Analysis and Structural Equation Modeling. Cary, NC SAS Institute Inc. 1994.
27. Fayers PM, Hand DJ. Factor analysis, causal indicators and quality of life. Qual Life Res 1997;6:139-150. (Pubitemid 27207279)
28. Zollner YF, Acquadro C, Schaefer M. Literature review of instruments to assess health-related quality of life during and after menopause. Qual Life Res 2005;14:309-327. (Pubitemid 40576383)